Characteristics of Articles Included in the Synthesis
Number | Author, Year | Sample Size (Setting) | Patients’ Age and Sex | Country | Methods | Relevancea | Pharmaceutical Funding |
---|---|---|---|---|---|---|---|
1 | Roebuck et al,27 2001 | 31 (CAD; 6 wk after discharge) | Median age = 63 y (28–74 y), 21 male | United Kingdom | Interviews | SAT | No |
2 | Wiles and Kinmonth,28 2001 | 25 (CAD; 2 and 16 wk after discharge) | Ages 34–80 y, 13 male | England | Interviews | SAT | No |
3 | Bergman and Berterö,29 2001 | 8 (CAD; 5–8 mo after diagnosis) | Ages 49–68 y, 5 male | Sweden | Interviews | SAT | No |
4 | Kärner et al,30 2002 | 23 (AMI; 1 y after CHD event) | Mean age = 51 y female, 57 y male; 14 male | Sweden | Interviews | SAT | No |
5 | Webster et al,31 2002 | 35 (AMI and spouses; 2–3 wk after discharge) | Average age = 65 y, 25 male | England | Interviews | SAT | No |
6 | Tolmie et al,32 2003 | 33 (CAD or high risk of CAD; 1–7 y after statin initiation) | Ages 24–80 y, 20 male | Scotland | Interviews | SAT | Yes |
7 | Kärner et al,33 2004 | 25 (spouses of CHD patients; 1 y after cardiac event) | Ages 36–68 y, 8 male | Sweden | Interviews | SAT | Not mentioned |
8 | Attebring et al,34 2005 | 20 (first AMI; median 7.5 wk after discharge) | Median age = 61.5 y (34–79 y), 12 male | Sweden | Interviews | KA | No |
9 | Lehane et al,35 2008 | 10 (CAD; average length of treatment 2.5 y) | Ages 51–69 y, 7 male | Ireland | Interviews | KA | Yes |
10 | Wang et al,36 2008 | 17 (first AMI; average 18 d after discharge) | Mean age = 57 y (39–73 y), 14 male | China | Focus groups | SAT | Not mentioned |
11a | Decker et al,37 2008 | 22 (NSTEMI with DES) | Ages 41–77 y, 13 male | United States | Interviews (telephone) | KA | Yes |
11b | Garavalia et al,38 2009 | 40 (AMI) | Ages 44–78 y, 20 male | United States | Interviews (telephone) | KA | Yes |
11c | Garavalia et al,39 2011 | 22 (AMI with DES) | Mean age = 53 y (45–77 y), 13 male | United States | Interviews (telephone) | KA | Yes |
12 | West et al,40 2010 | 32 (CHD admission; 3 mo after discharge) | Aged ≥62 y, all female | United States | Interviews | SAT | No |
13 | White et al,41 2010 | 15 (cardiac rehabilitation attendees; during program and 9 mo after it) | Aged 42–72 y, 11 male | England | Interviews | SAT | Not mentioned |
14 | Speechly et al,42 2010 | 13 (CHD; 8 diagnosed ≥5 y, 5 diagnosed <5 y) | Aged 50–75 y, 6 male | Australia | Interviews | SAT | Yes |
15 | Rushworth et al,43 2012 | 20 (PCI; after phase 1 cardiac rehabilitation) | Median age = 60.5 y, 15 male | Scotland | Interviews and questionnaires | KA | No |
AMI = acute myocardial infarction; CAD = coronary artery disease; CHD = coronary heart disease; DES = drug-eluting stent; KA = key article; NHS = National Health Service; NIH = National Institutes of Health; NSTEMI = non–ST-elevation myocardial infarction; PCI = percutaneous coronary intervention; SAT= satisfactory article.
↵a According to system of Dixon-Woods et al.24